Log in to save to my catalogue

Plasma prolidase levels as a biomarker for polycystic ovary syndrome

Plasma prolidase levels as a biomarker for polycystic ovary syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2051067078

Plasma prolidase levels as a biomarker for polycystic ovary syndrome

About this item

Full title

Plasma prolidase levels as a biomarker for polycystic ovary syndrome

Publisher

England: Future Medicine Ltd

Journal title

Biomarkers in medicine, 2018-06, Vol.12 (6), p.597-606

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

Assessment of plasma prolidase levels in polycystic ovary syndrome (PCOS).
PCOS patients were screened according to Rotterdam Criterion and prolidase levels were measured.
A total of 170 patients and 160 controls were recruited for the study and it was found that prolidase levels were significantly higher in PCOS group (991.10 ± 39.52) than c...

Alternative Titles

Full title

Plasma prolidase levels as a biomarker for polycystic ovary syndrome

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2051067078

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2051067078

Other Identifiers

ISSN

1752-0363

E-ISSN

1752-0371

DOI

10.2217/bmm-2017-0306

How to access this item